Finerenone is a non-steroidal mineralocorticoid receptor antagonist used to treat chronic kidney disease associated with type 2 diabetes. It works by blocking the action of hormones that can damage the kidneys. Finerenone is clinically significant for managing renal health. In summary, finerenone is essential for preserving kidney function in diabetic patients.
Finerenone selectively inhibits mineralocorticoid receptors, reducing fibrosis and inflammation in renal tissues.